VAXINE PTY LTD

1 Flinders Dr, Bedford Park, South Australia, Australia

Clinical Trials

3 active

Approvals

Total approvals

Agencies

Regulatory bodies

Founded

N/A

Overview

Trial Phase Distribution

Phase

Trials

Phase 1

82.3%

Phase 3

11.8%

Phase 2

5.9%

Trial Status Distribution

Active, not recruiting

11.8%

Completed

64.7%

Not yet recruiting

5.9%

Recruiting

17.6%

Clinical Trials

Trials sponsored by this organization (17)

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Phase 1

Not yet recruiting

interventional

Mar 202640 participants

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

Phase 3

Completed

interventional

Aug 202239 participants

Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

Phase 2

Active, not recruiting

interventional

Mar 2022200 participants

Monovalent Recombinant COVID19 Vaccine

Phase 1

Completed

interventional

Jun 202040 participants

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Phase 1

Completed

interventional

Jan 2017150 participants

Page 1 of 3

Approvals

No approval data available

News

No news articles found

Back to Organizations

VAXINE PTY LTD

Overview

Trial Phase Distribution

Trial Status Distribution

Clinical Trials

Trials sponsored by this organization (17)

A Randomised Controlled Phase 1 Study of Vaccine Therapy for Control or Cure of Chronic Hepatitis B Virus Infection

Covid-19 and Influenza Oral Vaccine Study

Autologous Tumour Vaccine Trial

Booster Study of SpikoGen COVID-19 Vaccine

A Phase 3b/4 Randomised Trial of 3 Doses of Protein-based Covid-19 Vaccine (SpikoGen)

Australian Phase 2b Study to Assess Effect of Dose Interval on Spikogen Covid-19 Vaccine

Monovalent Recombinant COVID19 Vaccine

Recombinant H7 Hemagglutinin Influenza Vaccine Trial

Approvals

News